Neoadjuvant docetaxel plus goserelin in patients with very-high risk, locally advanced prostate cancer: Initial results from a randomized study

Authors
Category Primary study
JournalEuropean Urology, Supplements
Year 2018
This article has no abstract
Epistemonikos ID: cbd0087fbb1c822e891b36ac28d9a64858c37ee7
First added on: Feb 09, 2025